Carl P. Sherr & Co. LLC Buys New Shares in HCA Healthcare, Inc. $HCA

Carl P. Sherr & Co. LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 575 shares of the company’s stock, valued at approximately $220,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Nuveen LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at $569,217,000. Pacer Advisors Inc. increased its stake in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after acquiring an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after buying an additional 587,036 shares during the period. Finally, Abdiel Capital Advisors LP acquired a new stake in shares of HCA Healthcare in the first quarter worth $164,835,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

HCA has been the topic of several recent research reports. Bank of America boosted their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. Robert W. Baird raised their target price on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a research note on Wednesday, October 8th. Truist Financial increased their target price on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Finally, Mizuho upped their price target on shares of HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Stock Down 0.2%

Shares of HCA opened at $472.40 on Friday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $480.00. The firm has a market capitalization of $107.80 billion, a PE ratio of 18.26, a P/E/G ratio of 1.38 and a beta of 1.41. The firm has a 50-day moving average price of $433.56 and a 200 day moving average price of $396.06.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period last year, the firm posted $4.90 earnings per share. The business’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.